Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin Abuse Potential Study in Recreational Sedative Users
NCT07777965Phase 4Completed
- Sponsor
- Viatris
- Start
- Jun 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of gabapentin (4 arms), sponsored by Viatris. Primary endpoint: Bipolar Visual Analog Scale (VAS) for 'Drug Liking' Maximum Effect (Emax) up to 24 hours. Started Jun 2026; status: completed.
02
Drugs
gabapentin
Beyond the preview
Go deeper on NCT07777965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07777965.